Alkermes plc (ALKS) has a market capitalization of $5.64B and trades at $33.87. The 52-week range is 25.17-36.48.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 23, Earnings Per Share (EPS) of $1.47, annual revenue of $1.48B.
The stock has a beta of 0.39, operates in the Healthcare sector.
